Nu Skin Enterprises (NUS) Misses Q4 EPS by 1c; Reiterates Outlook

Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.79, $0.01 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $531.3 million versus the consensus estimate of $553.19 million.

The company also reiterated guidance provided at its 2016 investor day in December with anticipated revenue of $2.26 to $2.30 billion and earnings per share of $3.10 to $3.25, assuming a 3 to 4 percent negative foreign currency impact.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c